Shire buys into regenerative medicine with Pervasis purchase

Article Date: 13/04/2012 10:00
Shire buys into regenerative medicine with Pervasis purchase

Vacancy Search

Quick job search

Advanced Search

Latest News

NICE backs Gilead's Harvoni for Hep C

NICE backs Gilead's Harvoni for Hep C

J&J sells Cordis to Cardinal for $1.94bn

J&J sells Cordis to Cardinal for $1.94bn

Taiho submits colorectal cancer drug in Europe

Taiho submits colorectal cancer drug in Europe

FEATURE: An era of openness

FEATURE: An era of openness

Shire files potential eye blockbuster in the US

Shire files potential eye blockbuster in the US

Two more NHS Foundation Trusts for England

Two more NHS Foundation Trusts for England

GSK, Novartis complete three-way mega deal

GSK, Novartis complete three-way mega deal

Weekly Market Movers (to 27 Feb 2015)

EvaluatePharma’s EventAnalyzer delivers a weekly global round up of key events driving company valuations.

Endo exits medtech – almost

Endo International is selling most of its remaining medtech unit – and selling it at what looks to be a loss. The company had bought American Medical Systems in 2011 for $2.9bn, but today...

GP leaders call for cash to protect care continuity

GP leaders call for cash to protect care continuity
more news